European genetic variants associated with type 2 diabetes in North African Arabs

S. Cauchi, I. Ezzidi, Y. El Achhab, N. Mtiraoui, L. Chaieb, D. Salah, C. Nejjari, Y. Labrune, L. Yengo, D. Beury, M. Vaxillaire, T. Mahjoub, M. Chikri, P. Froguel

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Aims: Recent genome-wide association studies (GWAS) and previous approaches have identified many genetic variants associated with type 2 diabetes (T2D) in populations of European descent, but their contribution in Arab populations from North Africa is unknown. Our study aimed to validate these markers and to assess their combined effects, using large case-control studies of Moroccan and Tunisian individuals. Methods: Overall, 44 polymorphisms, located at 37 validated European loci, were first analyzed in 1055 normoglycaemic controls and 1193 T2D cases from Morocco. Associations and trends were then assessed in 942 normoglycaemic controls and 1446 T2D cases from Tunisia. Finally, their ability to discriminate cases from controls was evaluated. Results: Carrying a genetic variant in BCL11A, ADAMTS9, IGF2BP2, WFS1, CDKAL1, TP53INP1, CDKN2A/B, TCF7L2, KCNQ1, HNF1A, FTO, MC4R and GCK increased the risk of T2D when assessing the Moroccan and Tunisian samples together. Each additional risk allele increased the susceptibility for developing the disease by 12% (P=9.0×10-9). Genotype information for 13 polymorphisms slightly improved the classification of North Africans with and without T2D, as assessed by clinical parameters, with an increase in the area under the receiver operating characteristic curve from 0.64 to 0.67 (P=0.004). Conclusion: In addition to TCF7L2, 12 additional loci were found to be shared between Europeans and North African Arabs. As for Europeans, the reliability of genetic testing based on these markers to determine the risk for T2D is low. More genome-wide studies, including next-generation sequencing, in North African populations are needed to identify the genetic variants responsible for ethnic disparities in T2D susceptibility.

Original languageEnglish
Pages (from-to)316-323
Number of pages8
JournalDiabetes and Metabolism
Volume38
Issue number4
DOIs
Publication statusPublished - 1 Oct 2012
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Population
Northern Africa
Morocco
Tunisia
Genome-Wide Association Study
Disease Susceptibility
Genetic Testing
ROC Curve
Case-Control Studies
Alleles
Genotype
Genome

Keywords

  • Morocco
  • Polymorphism
  • Tunisia
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Cauchi, S., Ezzidi, I., El Achhab, Y., Mtiraoui, N., Chaieb, L., Salah, D., ... Froguel, P. (2012). European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes and Metabolism, 38(4), 316-323. https://doi.org/10.1016/j.diabet.2012.02.003

European genetic variants associated with type 2 diabetes in North African Arabs. / Cauchi, S.; Ezzidi, I.; El Achhab, Y.; Mtiraoui, N.; Chaieb, L.; Salah, D.; Nejjari, C.; Labrune, Y.; Yengo, L.; Beury, D.; Vaxillaire, M.; Mahjoub, T.; Chikri, M.; Froguel, P.

In: Diabetes and Metabolism, Vol. 38, No. 4, 01.10.2012, p. 316-323.

Research output: Contribution to journalArticle

Cauchi, S, Ezzidi, I, El Achhab, Y, Mtiraoui, N, Chaieb, L, Salah, D, Nejjari, C, Labrune, Y, Yengo, L, Beury, D, Vaxillaire, M, Mahjoub, T, Chikri, M & Froguel, P 2012, 'European genetic variants associated with type 2 diabetes in North African Arabs', Diabetes and Metabolism, vol. 38, no. 4, pp. 316-323. https://doi.org/10.1016/j.diabet.2012.02.003
Cauchi S, Ezzidi I, El Achhab Y, Mtiraoui N, Chaieb L, Salah D et al. European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes and Metabolism. 2012 Oct 1;38(4):316-323. https://doi.org/10.1016/j.diabet.2012.02.003
Cauchi, S. ; Ezzidi, I. ; El Achhab, Y. ; Mtiraoui, N. ; Chaieb, L. ; Salah, D. ; Nejjari, C. ; Labrune, Y. ; Yengo, L. ; Beury, D. ; Vaxillaire, M. ; Mahjoub, T. ; Chikri, M. ; Froguel, P. / European genetic variants associated with type 2 diabetes in North African Arabs. In: Diabetes and Metabolism. 2012 ; Vol. 38, No. 4. pp. 316-323.
@article{47b3062c7be7411ebe940ff814e69eb8,
title = "European genetic variants associated with type 2 diabetes in North African Arabs",
abstract = "Aims: Recent genome-wide association studies (GWAS) and previous approaches have identified many genetic variants associated with type 2 diabetes (T2D) in populations of European descent, but their contribution in Arab populations from North Africa is unknown. Our study aimed to validate these markers and to assess their combined effects, using large case-control studies of Moroccan and Tunisian individuals. Methods: Overall, 44 polymorphisms, located at 37 validated European loci, were first analyzed in 1055 normoglycaemic controls and 1193 T2D cases from Morocco. Associations and trends were then assessed in 942 normoglycaemic controls and 1446 T2D cases from Tunisia. Finally, their ability to discriminate cases from controls was evaluated. Results: Carrying a genetic variant in BCL11A, ADAMTS9, IGF2BP2, WFS1, CDKAL1, TP53INP1, CDKN2A/B, TCF7L2, KCNQ1, HNF1A, FTO, MC4R and GCK increased the risk of T2D when assessing the Moroccan and Tunisian samples together. Each additional risk allele increased the susceptibility for developing the disease by 12{\%} (P=9.0×10-9). Genotype information for 13 polymorphisms slightly improved the classification of North Africans with and without T2D, as assessed by clinical parameters, with an increase in the area under the receiver operating characteristic curve from 0.64 to 0.67 (P=0.004). Conclusion: In addition to TCF7L2, 12 additional loci were found to be shared between Europeans and North African Arabs. As for Europeans, the reliability of genetic testing based on these markers to determine the risk for T2D is low. More genome-wide studies, including next-generation sequencing, in North African populations are needed to identify the genetic variants responsible for ethnic disparities in T2D susceptibility.",
keywords = "Morocco, Polymorphism, Tunisia, Type 2 diabetes",
author = "S. Cauchi and I. Ezzidi and {El Achhab}, Y. and N. Mtiraoui and L. Chaieb and D. Salah and C. Nejjari and Y. Labrune and L. Yengo and D. Beury and M. Vaxillaire and T. Mahjoub and M. Chikri and P. Froguel",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.diabet.2012.02.003",
language = "English",
volume = "38",
pages = "316--323",
journal = "Diabetes and Metabolism",
issn = "1262-3636",
publisher = "Elsevier Masson",
number = "4",

}

TY - JOUR

T1 - European genetic variants associated with type 2 diabetes in North African Arabs

AU - Cauchi, S.

AU - Ezzidi, I.

AU - El Achhab, Y.

AU - Mtiraoui, N.

AU - Chaieb, L.

AU - Salah, D.

AU - Nejjari, C.

AU - Labrune, Y.

AU - Yengo, L.

AU - Beury, D.

AU - Vaxillaire, M.

AU - Mahjoub, T.

AU - Chikri, M.

AU - Froguel, P.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Aims: Recent genome-wide association studies (GWAS) and previous approaches have identified many genetic variants associated with type 2 diabetes (T2D) in populations of European descent, but their contribution in Arab populations from North Africa is unknown. Our study aimed to validate these markers and to assess their combined effects, using large case-control studies of Moroccan and Tunisian individuals. Methods: Overall, 44 polymorphisms, located at 37 validated European loci, were first analyzed in 1055 normoglycaemic controls and 1193 T2D cases from Morocco. Associations and trends were then assessed in 942 normoglycaemic controls and 1446 T2D cases from Tunisia. Finally, their ability to discriminate cases from controls was evaluated. Results: Carrying a genetic variant in BCL11A, ADAMTS9, IGF2BP2, WFS1, CDKAL1, TP53INP1, CDKN2A/B, TCF7L2, KCNQ1, HNF1A, FTO, MC4R and GCK increased the risk of T2D when assessing the Moroccan and Tunisian samples together. Each additional risk allele increased the susceptibility for developing the disease by 12% (P=9.0×10-9). Genotype information for 13 polymorphisms slightly improved the classification of North Africans with and without T2D, as assessed by clinical parameters, with an increase in the area under the receiver operating characteristic curve from 0.64 to 0.67 (P=0.004). Conclusion: In addition to TCF7L2, 12 additional loci were found to be shared between Europeans and North African Arabs. As for Europeans, the reliability of genetic testing based on these markers to determine the risk for T2D is low. More genome-wide studies, including next-generation sequencing, in North African populations are needed to identify the genetic variants responsible for ethnic disparities in T2D susceptibility.

AB - Aims: Recent genome-wide association studies (GWAS) and previous approaches have identified many genetic variants associated with type 2 diabetes (T2D) in populations of European descent, but their contribution in Arab populations from North Africa is unknown. Our study aimed to validate these markers and to assess their combined effects, using large case-control studies of Moroccan and Tunisian individuals. Methods: Overall, 44 polymorphisms, located at 37 validated European loci, were first analyzed in 1055 normoglycaemic controls and 1193 T2D cases from Morocco. Associations and trends were then assessed in 942 normoglycaemic controls and 1446 T2D cases from Tunisia. Finally, their ability to discriminate cases from controls was evaluated. Results: Carrying a genetic variant in BCL11A, ADAMTS9, IGF2BP2, WFS1, CDKAL1, TP53INP1, CDKN2A/B, TCF7L2, KCNQ1, HNF1A, FTO, MC4R and GCK increased the risk of T2D when assessing the Moroccan and Tunisian samples together. Each additional risk allele increased the susceptibility for developing the disease by 12% (P=9.0×10-9). Genotype information for 13 polymorphisms slightly improved the classification of North Africans with and without T2D, as assessed by clinical parameters, with an increase in the area under the receiver operating characteristic curve from 0.64 to 0.67 (P=0.004). Conclusion: In addition to TCF7L2, 12 additional loci were found to be shared between Europeans and North African Arabs. As for Europeans, the reliability of genetic testing based on these markers to determine the risk for T2D is low. More genome-wide studies, including next-generation sequencing, in North African populations are needed to identify the genetic variants responsible for ethnic disparities in T2D susceptibility.

KW - Morocco

KW - Polymorphism

KW - Tunisia

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84866755863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866755863&partnerID=8YFLogxK

U2 - 10.1016/j.diabet.2012.02.003

DO - 10.1016/j.diabet.2012.02.003

M3 - Article

VL - 38

SP - 316

EP - 323

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

SN - 1262-3636

IS - 4

ER -